About
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Team & affiliation
Founders: [object Object], [object Object], [object Object], [object Object].
Region context
Ambulero is one of 7 Biotechnology companies we track in undefined, based in Miami — about 2% of the region's 286 startups.